Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 5 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed with results

Key Signals

1 with results100% success

Data Visualizations

Phase Distribution

3Total

Not Applicable (2)

P 2 (1)

Trial Status

Completed3

Enrolling By Invitation1

Unknown1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 3 completed trials

Clinical Trials (5)

Showing 5 of 5 trials

NCT06689696Completed

24-hour Wear Performance and Safety Study of Smartlens miLens Contact Lens for IOP Monitoring

NCT06857032Enrolling By Invitation

Long-term Safety and Effectiveness of LASIK-Xtra Compared to Conventional LASIK

NCT03396315Phase 2CompletedPrimary

Bisphosphonates for Prevention of Post-Denosumab Bone Loss

NCT03318146Not ApplicableUnknown

Safety, Tolerability and Preliminary Efficacy of Unilateral Latanoprost-loaded Punctual Plug -EXP-LP

NCT03107429Not ApplicableCompletedPrimary

Effect of Acetazolamide on Intraocular Pressure After Being in the Trendelenburg Position.

Showing all 5 trials

IOP